A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00002319. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the safety and effectiveness of Stealth liposomal doxorubicin hydrochloride (DOX-SL) in the long-term treatment of AIDS-related Kaposi's sarcoma (KS) in patients who previously had good responses to DOX-SL in controlled studies of limited duration, or those with KS who discontinued treatment with another Kaposi's sarcoma therapy because of inadequate efficacy or unacceptable toxicity. To provide a defined protocol for Kaposi's sarcoma patients for whom DOX-SL therapy is indicated.
Study identification
- NCT ID
- NCT00002319
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 24, 2005
United States locations
- U.S. sites
- 33
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| East Bay AIDS Ctr | Berkeley | California | 94705 | — |
| Pacific Oaks Med Group | Beverly Hills | California | 90211 | — |
| Hematology - Oncology Med Group of San Fernando Valley | Encino | California | 91436 | — |
| Dr Becky Miller | Los Angeles | California | 90048 | — |
| Apogee Med Group | San Diego | California | 92103 | — |
| UCSF - San Francisco Gen Hosp | San Francisco | California | 94110 | — |
| Kaiser Permanente Med Ctr | San Francisco | California | 94115 | — |
| UCSF | San Francisco | California | 94117 | — |
| San Francisco Veterans Administration Med Ctr | San Francisco | California | 94121 | — |
| UCSF | San Francisco | California | 941430324 | — |
| Pacific Oaks Med Group | Sherman Oaks | California | 91403 | — |
| Dr Mahmoud Mustafa | Washington D.C. | District of Columbia | 20037 | — |
| Univ of Miami School of Medicine | Miami | Florida | 33136 | — |
| H Lee Moffit Cancer Ctr and Research Institute | Tampa | Florida | 33612 | — |
| American Med Research Institute | Atlanta | Georgia | 30329 | — |
| Infectious Disease Rsch Consortium of GA / SE Clin Resources | Atlanta | Georgia | 30345 | — |
| Northwestern Med Faculty Foundation | Chicago | Illinois | 60611 | — |
| Rush Presbyterian Med College | Chicago | Illinois | 60612 | — |
| Illinois Masonic Med Ctr / The Cancer Ctr | Chicago | Illinois | 60657 | — |
| Henry Ford Hosp | Detroit | Michigan | 48202 | — |
| Washington Univ | St Louis | Missouri | 63108 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Saint Vincent's Hosp and Med Ctr | New York | New York | 10011 | — |
| New York Univ Med Ctr | New York | New York | 10016 | — |
| Mem Sloan - Kettering Cancer Ctr | New York | New York | 10021 | — |
| Saint Luke's - Roosevelt Hosp Ctr | New York | New York | 10023 | — |
| Mount Sinai Med Ctr | New York | New York | 10029 | — |
| Graduate Hosp / Tuttleman Cancer Ctr | Philadelphia | Pennsylvania | 19146 | — |
| Comprehensive Care Ctr | Dallas | Texas | 75235 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Houston Immunological Institute | Houston | Texas | 77054 | — |
| Twelve Oaks Hosp | Houston | Texas | 77074 | — |
| Virginia Mason Research Center / Clinical Trial Unit | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002319, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.